HI SB, the science is only one part of the equation mate. The financial part of the equation needs to be what to realise this IP? What amount of funding needed to put a rocket under this science?
It does concern me that there is very little talk by Anteris on this concern (funding requirements for the future), all the attention is 100% on the science.
What would be great is to see this panel of experts each buy in significantly (?), pipe dream perhaps but the sentiment it could generate?
Not sure why sellers are stilling feeding the ‘sell’ side, especially after that cross trade recently.
End of year should reveal the answers to a few pertinent questions.
Imo, not advice.
Ann: AGM Chairman's address and CEO Presentation, page-28
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
-0.300(1.73%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| $17.00 | $17.44 | $16.95 | $184.6K | 10.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 191 | $17.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.50 | 500 | 1 |
View Market Depth
| Last trade - 15.59pm 19/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |